Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 358 participants.

Also called NCT06059144

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 358 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06059144
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06059144. Randomized; single masking; primary purpose treatment. Start 2024-11-28 (actual); primary completion 2027-08-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine
Acronym
PRESSURE
Condition
Stroke, Acute
Condition
Stroke, Ischemic
Intervention (Drug)
Peripheral intravenous norepinephrine
Lead sponsor
University Hospital, Bordeaux (class: other)

Record details

Record id
cardio:ct-nct06059144
Content hash
b7be12aadfac019e63a191ce19975306e41937f837ec3ade158bd3404a52075c